Literature DB >> 27601166

Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).

Yating Wang1, Chen Chen2, Xiaofei Wang3, Fengtong Jin3, Yan Liu3, Huiqiao Liu3, Ting Li3, Jiangtao Fu4.   

Abstract

PURPOSE: Although desmocollins have an important position in cancer-related research, there are little reports about the relations between cancers and desmocollin 1 (DSC1). The present study was designed to investigate the correlations between DSC1 and head and neck squamous cell carcinoma (HNSCC).
METHODS: First we analyzed the GEO database; then, HNSCC and pericarcinous tissues were collected to verify the results. DSC1 expression was detected by western blot and real-time PCR. The co-expression genes of DSC1 were extracted from Cancer Cell Line Encyclopedia database (CCLE database), and their correlation was analyzed in The Cancer Genome Atlas HNSCC database (TCGA HNSCC database). Next the gene ontology analysis (GO) was carried out. Moreover, we suppressed DSC1 in FaDu cell to investigate the internal mechanism.
RESULTS: GEO database showed that DSC1 was higher in HNSCC and patients with higher DSC1 had unfavorable prognosis. The results of the samples showed that DSC1 was significantly higher in HNSCC than in normal tissue, which was consistent with the results of GEO database. The co-expression genes of DSC1 were extracted from CCLE database and verified in TCGA HNSCC database. It revealed that DSC1 was related to cell signal transduction. In FaDu/siDSC1 cells, the proliferation and migration were decreased compared to FaDu cells, and the expression levels of β-catenin, c-myc and cyclin D1 down-regulated significantly.
CONCLUSIONS: The increased expression of DSC1 can promote the occurrence of HNSCC and is associated with tumor. The increased expression of DSC1 also indicates a poor prognosis of the patients with HNSCC.

Entities:  

Keywords:  Biomarker; DSC1; GEO dataset; HNSCC; Tissue microassay

Mesh:

Substances:

Year:  2016        PMID: 27601166     DOI: 10.1007/s00432-016-2233-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

Review 1.  Pemphigus herpetiformis with IgG autoantibodies to desmoglein 1 and desmocollin 1.

Authors:  H R On; T Hashimoto; S-C Kim
Journal:  Br J Dermatol       Date:  2015-02-25       Impact factor: 9.302

2.  Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis.

Authors:  J Depondt; A H Shabana; S Florescu-Zorila; P Gehanno; N Forest
Journal:  Eur J Oral Sci       Date:  1999-06       Impact factor: 2.612

3.  Heterogeneous and abnormal localization of desmosomal proteins in oral intraepithelial neoplasms.

Authors:  Sohichi Aizawa; Takanaga Ochiai; Toshiaki Ara; Haruki Yamada; Hiromasa Hasegawa
Journal:  J Oral Sci       Date:  2014-09       Impact factor: 1.556

Review 4.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

5.  Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion.

Authors:  Spiro Getsios; Evangeline V Amargo; Rachel L Dusek; Ken Ishii; Linda Sheu; Lisa M Godsel; Kathleen J Green
Journal:  Differentiation       Date:  2004-10       Impact factor: 3.880

6.  Gene Expression Characterization of HPV Positive Head and Neck Cancer to Predict Response to Chemoradiation.

Authors:  Bryan J Thibodeau; Timothy J Geddes; Laura E Fortier; Samreen Ahmed; Barbara L Pruetz; Jessica Wobb; Peter Chen; George D Wilson; Jan A Akervall
Journal:  Head Neck Pathol       Date:  2014-12-07

7.  Desmocollin 1 expression and desmosomal remodeling during terminal differentiation of human anagen hair follicle: an electron microscopic study.

Authors:  Elena Donetti; Elena Boschini; Anna Cerini; Silvia Selleri; Cristiano Rumio; Isabella Barajon
Journal:  Exp Dermatol       Date:  2004-05       Impact factor: 3.960

8.  Trangenic misexpression of the differentiation-specific desmocollin isoform 1 in basal keratinocytes.

Authors:  F Henkler; M Strom; K Mathers; H Cordingley; K Sullivan; I King
Journal:  J Invest Dermatol       Date:  2001-01       Impact factor: 8.551

9.  The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases.

Authors:  Silke Schüle; Claudia Neuhäuser; Falk Rauchfuß; Thomas Knösel; Utz Settmacher; Annelore Altendorf-Hofmann
Journal:  Int J Colorectal Dis       Date:  2013-08-24       Impact factor: 2.571

10.  Desmocollin switching in colorectal cancer.

Authors:  K Khan; R Hardy; A Haq; O Ogunbiyi; D Morton; M Chidgey
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

View more
  4 in total

1.  MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer.

Authors:  Shuqin Jia; Jiajia Lu; Tingting Qu; Yi Feng; Xiaohong Wang; Caixia Liu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

2.  POSITIVE EXPRESSION OF NEDD9 IN HEAD AND NECK CANCER IS RELATED TO BETTER SURVIVAL PERIOD.

Authors:  Iva Ledinsky Opačić; Krešimir Gršić; Sanda Šitić; Ivan Penavić; Marija Pastorčić Grgić; Božena Šarčević
Journal:  Acta Clin Croat       Date:  2019-12       Impact factor: 0.780

3.  FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients.

Authors:  Yating Wang; Yan Liu; Huiqiao Liu; Qingan Zhang; Hongyan Song; Jianliang Tang; Jiangtao Fu; Xiaofei Wang
Journal:  Oncotarget       Date:  2017-09-23

4.  Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.

Authors:  Ruiying Sun; Chao Ma; Wei Wang; Shuanying Yang
Journal:  PeerJ       Date:  2020-02-13       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.